VANCOUVER, BC, Jan. 21, 2015 (GLOBE NEWSWIRE) -- via PRWEB - According to a recent report by iData Research (http://www.idataresearch.com), the leading global authority in medical device market research, the U.S. percutaneous transluminal angioplasty (PTA) balloon catheter market is estimated to be worth over $500 million by 2020. This market includes standard, high-pressure, large, small and specialty balloons.
Specialty balloons were the fastest-growing segment in the market in 2014, followed by small balloons. Specialty balloons include cryoplasty balloons, cutting and scoring balloons and drug-coated balloons (DCBs). "Because of their growing popularity and their premium price, specialty balloons are expected to become the largest segment in the PTA balloon market," explains Dr. Kamran Zamanian, CEO of iData. Nonetheless, standard balloons will continue be used in conjunction with stents in angioplasty procedures, leading to robust growth.
Ongoing investment in the development of drug-coated balloons by leading companies in the field has the potential to rapidly increase demand for PTA balloons and alter the entire market for peripheral vascular devices by replacing the need for stents for certain procedures. Major acquisitions in the peripheral vascular market for 2012 and 2013 have been related to the purchase of companies engaged in the development of drug-coated balloon technology. In August 2013, Medtronic announced submission of its premarket approval module for its IN.PACT Admiral™ DCB. The company received their FDA approval last week for the treatment of peripheral artery disease (PAD) in the upper leg.
Other competitors leading the U.S. PTA balloon market include Boston Scientific, offering at least one product in every segment, C.R. Bard, Cordis, Covidien and AngioScore.
Other key findings from the U.S. PTA balloon catheter market include:
High Restenosis Rates
Restenosis, a re-narrowing of the vascular lumen, occurs in roughly a third of patients that undergo balloon angioplasty. Thus, a portion of the PTA balloon market will be the result of repeated treatments at the same location.
Increase in Hemodialysis Patients
PTA balloons are deployed in a number of hemodialysis procedures. For example, high-pressure balloons are used for clearing AV grafts, and large balloons are deployed to facilitate central-venous catheter access. As a result, the increasing number of hemodialysis patients is expected to drive the demand for PTA balloons.
For more information
The U.S. PTA balloon catheter market is part of the "U.S. peripheral vascular device market report suite. The global series on the peripheral vascular device market covers 20 countries including the U.S., Canada, China, India, Japan, and 15 countries in Europe. Full reports provide a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players' success strategies in each market and segment.
The reports cover markets for:
- Peripheral Vascular Stent Market
- PTA Balloon Catheter Market
- Atherectomy Device Market
- Chronic Total Occlusion (CTO) Device Market
- Embolic Protection Device Market
- Stent Graft Market
- Surgical Graft Market
- AV Access Thrombectomy Device Market
- Inferior Vena Cava Filter Market
- Diagnostic and Interventional Catheter Market
- Diagnostic and Interventional Guidewire Market
- Introducer Sheath Market
- Vascular Closure Device Market
- Transcatheter Embolization Device Market
Register online or email us at info@idataresearch.net for a U.S. peripheral vascular device market report synopsis.
About iData Research
iData Research (http://www.idataresearch.com) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmics, Endoscopy, Gynecology, Urology and more.
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/01/prweb12448683.htm